EMEA-001066-PIP02-11-M03

Key facts

Invented name
Sitavig and associated names
Active substance
Aciclovir
Therapeutic area
Infectious diseases
Decision number
P/0412/2019
PIP number
EMEA-001066-PIP02-11-M03
Pharmaceutical form(s)
Muco-adhesive buccal tablet
Condition(s) / indication(s)
Treatment of herpes simplex labialis
Route(s) of administration
Gingival use
Contact for public enquiries
Vectans Pharma

Tel. +33 631268926
E-mail: christiane.bober@vectans.com

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating
Average
1 rating